nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—FMO3—sweat—sclerosing cholangitis	0.169	0.286	CbGeAlD
Vandetanib—ORM1—bile—sclerosing cholangitis	0.0553	0.0934	CbGeAlD
Vandetanib—PDGFRB—gall bladder—sclerosing cholangitis	0.0164	0.0277	CbGeAlD
Vandetanib—VEGFA—NOTCH1 regulation of human endothelial cell calcification—ALPL—sclerosing cholangitis	0.0162	0.0397	CbGpPWpGaD
Vandetanib—VEGFA—miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma —HIF1A—sclerosing cholangitis	0.0159	0.0389	CbGpPWpGaD
Vandetanib—ORM1—gall bladder—sclerosing cholangitis	0.0153	0.0259	CbGeAlD
Vandetanib—ERBB3—a6b1 and a6b4 Integrin signaling—MST1—sclerosing cholangitis	0.0147	0.036	CbGpPWpGaD
Vandetanib—STK35—pancreas—sclerosing cholangitis	0.0143	0.0242	CbGeAlD
Vandetanib—ALB—gall bladder—sclerosing cholangitis	0.0134	0.0227	CbGeAlD
Vandetanib—TEK—Wnt Signaling Pathway Netpath—TCF4—sclerosing cholangitis	0.0134	0.0328	CbGpPWpGaD
Vandetanib—VEGFA—pancreas—sclerosing cholangitis	0.0131	0.0222	CbGeAlD
Vandetanib—VEGFA—Regulation of gene expression by Hypoxia-inducible Factor—HIF1A—sclerosing cholangitis	0.013	0.0318	CbGpPWpGaD
Vandetanib—ERBB3—pancreas—sclerosing cholangitis	0.0126	0.0213	CbGeAlD
Vandetanib—ABCC1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.0122	0.0299	CbGpPWpGaD
Vandetanib—SLK—pancreas—sclerosing cholangitis	0.0112	0.019	CbGeAlD
Vandetanib—TEK—Angiogenesis—HIF1A—sclerosing cholangitis	0.011	0.027	CbGpPWpGaD
Vandetanib—LYN—liver—sclerosing cholangitis	0.0109	0.0184	CbGeAlD
Vandetanib—TEK—pancreas—sclerosing cholangitis	0.0107	0.018	CbGeAlD
Vandetanib—MAP4K5—pancreas—sclerosing cholangitis	0.0107	0.018	CbGeAlD
Vandetanib—YES1—pancreas—sclerosing cholangitis	0.00984	0.0166	CbGeAlD
Vandetanib—SRC—pancreas—sclerosing cholangitis	0.00946	0.016	CbGeAlD
Vandetanib—FLT3—liver—sclerosing cholangitis	0.00928	0.0157	CbGeAlD
Vandetanib—BLK—Apoptosis Modulation and Signaling—TNFRSF25—sclerosing cholangitis	0.00915	0.0224	CbGpPWpGaD
Vandetanib—STK35—liver—sclerosing cholangitis	0.00909	0.0154	CbGeAlD
Vandetanib—ABL2—liver—sclerosing cholangitis	0.00886	0.015	CbGeAlD
Vandetanib—EGFR—liver—sclerosing cholangitis	0.00865	0.0146	CbGeAlD
Vandetanib—FLT4—liver—sclerosing cholangitis	0.00843	0.0143	CbGeAlD
Vandetanib—RIPK2—liver—sclerosing cholangitis	0.00838	0.0142	CbGeAlD
Vandetanib—VEGFA—liver—sclerosing cholangitis	0.00836	0.0141	CbGeAlD
Vandetanib—FMO1—liver—sclerosing cholangitis	0.00831	0.0141	CbGeAlD
Vandetanib—ABL1—CDO in myogenesis—TCF4—sclerosing cholangitis	0.00826	0.0202	CbGpPWpGaD
Vandetanib—EGFR—a6b1 and a6b4 Integrin signaling—MST1—sclerosing cholangitis	0.0082	0.0201	CbGpPWpGaD
Vandetanib—IRAK4—liver—sclerosing cholangitis	0.00818	0.0138	CbGeAlD
Vandetanib—ERBB3—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.00803	0.0196	CbGpPWpGaD
Vandetanib—ERBB3—liver—sclerosing cholangitis	0.00802	0.0136	CbGeAlD
Vandetanib—IRAK4—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00756	0.0185	CbGpPWpGaD
Vandetanib—PDGFRB—pancreas—sclerosing cholangitis	0.00754	0.0127	CbGeAlD
Vandetanib—MKNK1—liver—sclerosing cholangitis	0.00753	0.0127	CbGeAlD
Vandetanib—RIPK2—p75(NTR)-mediated signaling—BCL2L11—sclerosing cholangitis	0.00748	0.0183	CbGpPWpGaD
Vandetanib—FGR—liver—sclerosing cholangitis	0.00744	0.0126	CbGeAlD
Vandetanib—LCK—liver—sclerosing cholangitis	0.00744	0.0126	CbGeAlD
Vandetanib—MKNK1—Signaling mediated by p38-alpha and p38-beta—NOS2—sclerosing cholangitis	0.00742	0.0181	CbGpPWpGaD
Vandetanib—AXL—liver—sclerosing cholangitis	0.00741	0.0125	CbGeAlD
Vandetanib—FMO3—liver—sclerosing cholangitis	0.00719	0.0122	CbGeAlD
Vandetanib—SLK—liver—sclerosing cholangitis	0.00713	0.0121	CbGeAlD
Vandetanib—FYN—liver—sclerosing cholangitis	0.00694	0.0117	CbGeAlD
Vandetanib—MAP4K5—liver—sclerosing cholangitis	0.00678	0.0115	CbGeAlD
Vandetanib—TEK—liver—sclerosing cholangitis	0.00678	0.0115	CbGeAlD
Vandetanib—ABL1—pancreas—sclerosing cholangitis	0.00672	0.0114	CbGeAlD
Vandetanib—KDR—Angiogenesis—HIF1A—sclerosing cholangitis	0.0066	0.0162	CbGpPWpGaD
Vandetanib—RIPK2—p75 NTR receptor-mediated signalling—BCL2L11—sclerosing cholangitis	0.00652	0.016	CbGpPWpGaD
Vandetanib—YES1—liver—sclerosing cholangitis	0.00626	0.0106	CbGeAlD
Vandetanib—STK10—liver—sclerosing cholangitis	0.0062	0.0105	CbGeAlD
Vandetanib—ABCC1—Synthesis of Leukotrienes (LT) and Eoxins (EX)—GGT1—sclerosing cholangitis	0.00617	0.0151	CbGpPWpGaD
Vandetanib—SRC—liver—sclerosing cholangitis	0.00602	0.0102	CbGeAlD
Vandetanib—VEGFA—Angiogenesis—HIF1A—sclerosing cholangitis	0.00594	0.0145	CbGpPWpGaD
Vandetanib—BLK—Apoptosis Modulation and Signaling—BCL2L11—sclerosing cholangitis	0.00577	0.0141	CbGpPWpGaD
Vandetanib—VEGFA—Cellular response to hypoxia—HIF1A—sclerosing cholangitis	0.00575	0.0141	CbGpPWpGaD
Vandetanib—VEGFA—Endochondral Ossification—ALPL—sclerosing cholangitis	0.00562	0.0137	CbGpPWpGaD
Vandetanib—KDR—liver—sclerosing cholangitis	0.00554	0.00937	CbGeAlD
Vandetanib—MAP2K5—liver—sclerosing cholangitis	0.00554	0.00937	CbGeAlD
Vandetanib—ABL1—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.00523	0.0128	CbGpPWpGaD
Vandetanib—VEGFA—Alpha9 beta1 integrin signaling events—NOS2—sclerosing cholangitis	0.00523	0.0128	CbGpPWpGaD
Vandetanib—VEGFA—VEGFR1 specific signals—HIF1A—sclerosing cholangitis	0.0051	0.0125	CbGpPWpGaD
Vandetanib—PDGFRB—liver—sclerosing cholangitis	0.00479	0.00811	CbGeAlD
Vandetanib—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.00478	0.0117	CbGpPWpGaD
Vandetanib—ORM1—liver—sclerosing cholangitis	0.0045	0.00761	CbGeAlD
Vandetanib—EGFR—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.00447	0.0109	CbGpPWpGaD
Vandetanib—TEK—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00441	0.0108	CbGpPWpGaD
Vandetanib—ABL1—liver—sclerosing cholangitis	0.00427	0.00723	CbGeAlD
Vandetanib—VEGFA—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00421	0.0103	CbGpPWpGaD
Vandetanib—ALB—liver—sclerosing cholangitis	0.00394	0.00667	CbGeAlD
Vandetanib—KDR—Notch-mediated HES/HEY network—HIF1A—sclerosing cholangitis	0.00386	0.00944	CbGpPWpGaD
Vandetanib—ABL1—p73 transcription factor network—BCL2L11—sclerosing cholangitis	0.00386	0.00944	CbGpPWpGaD
Vandetanib—SRC—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.00381	0.00933	CbGpPWpGaD
Vandetanib—MAP2K5—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.0038	0.0093	CbGpPWpGaD
Vandetanib—IRAK4—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00365	0.00893	CbGpPWpGaD
Vandetanib—FMO1—Biological oxidations—GGT1—sclerosing cholangitis	0.00346	0.00846	CbGpPWpGaD
Vandetanib—EGFR—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00336	0.00822	CbGpPWpGaD
Vandetanib—MAP2K5—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00335	0.0082	CbGpPWpGaD
Vandetanib—IRAK4—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.00332	0.00812	CbGpPWpGaD
Vandetanib—ABCC1—liver—sclerosing cholangitis	0.00325	0.0055	CbGeAlD
Vandetanib—RIPK2—IL12-mediated signaling events—NOS2—sclerosing cholangitis	0.00324	0.00793	CbGpPWpGaD
Vandetanib—SRC—Angiogenesis—HIF1A—sclerosing cholangitis	0.0031	0.00759	CbGpPWpGaD
Vandetanib—ABCC1—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00308	0.00754	CbGpPWpGaD
Vandetanib—ABL1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00302	0.00739	CbGpPWpGaD
Vandetanib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.003	0.00734	CbGpPWpGaD
Vandetanib—ABL1—DNA Damage Response (only ATM dependent)—BCL2L11—sclerosing cholangitis	0.00298	0.0073	CbGpPWpGaD
Vandetanib—SRC—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00286	0.00701	CbGpPWpGaD
Vandetanib—RET—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.00277	0.00677	CbGpPWpGaD
Vandetanib—SRC—Alpha9 beta1 integrin signaling events—NOS2—sclerosing cholangitis	0.00273	0.00668	CbGpPWpGaD
Vandetanib—ABCG2—liver—sclerosing cholangitis	0.00269	0.00456	CbGeAlD
Vandetanib—VEGFA—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00268	0.00655	CbGpPWpGaD
Vandetanib—VEGFA—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.00264	0.00647	CbGpPWpGaD
Vandetanib—EGFR—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00258	0.00631	CbGpPWpGaD
Vandetanib—FGR—Platelet homeostasis—NOS2—sclerosing cholangitis	0.00252	0.00616	CbGpPWpGaD
Vandetanib—FMO3—Biological oxidations—GGT1—sclerosing cholangitis	0.00247	0.00605	CbGpPWpGaD
Vandetanib—EPHA5—Developmental Biology—TCF4—sclerosing cholangitis	0.00242	0.00593	CbGpPWpGaD
Vandetanib—ABL2—Developmental Biology—TCF4—sclerosing cholangitis	0.00242	0.00593	CbGpPWpGaD
Vandetanib—VEGFA—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.0024	0.00588	CbGpPWpGaD
Vandetanib—RIPK2—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.0024	0.00587	CbGpPWpGaD
Vandetanib—FYN—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00236	0.00578	CbGpPWpGaD
Vandetanib—EPHA8—Developmental Biology—TCF4—sclerosing cholangitis	0.00234	0.00572	CbGpPWpGaD
Vandetanib—SRC—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.0022	0.00539	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00219	0.00537	CbGpPWpGaD
Vandetanib—EPHB6—Developmental Biology—TCF4—sclerosing cholangitis	0.00217	0.00532	CbGpPWpGaD
Vandetanib—ERBB3—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00212	0.00518	CbGpPWpGaD
Vandetanib—FYN—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00208	0.00509	CbGpPWpGaD
Vandetanib—EPHA6—Developmental Biology—TCF4—sclerosing cholangitis	0.00204	0.005	CbGpPWpGaD
Vandetanib—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00196	0.0048	CbGpPWpGaD
Vandetanib—CYP3A4—liver—sclerosing cholangitis	0.00188	0.00317	CbGeAlD
Vandetanib—FMO3—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.00186	0.00455	CbGpPWpGaD
Vandetanib—SRC—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00174	0.00426	CbGpPWpGaD
Vandetanib—LCK—Notch Signaling Pathway—HIF1A—sclerosing cholangitis	0.00166	0.00407	CbGpPWpGaD
Vandetanib—EGFR—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00162	0.00396	CbGpPWpGaD
Vandetanib—SRC—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00153	0.00376	CbGpPWpGaD
Vandetanib—LCK—IL12-mediated signaling events—NOS2—sclerosing cholangitis	0.00153	0.00375	CbGpPWpGaD
Vandetanib—ABCG2—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.00151	0.0037	CbGpPWpGaD
Vandetanib—EGFR—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.00147	0.0036	CbGpPWpGaD
Vandetanib—SRC—Notch Signaling Pathway—HIF1A—sclerosing cholangitis	0.00147	0.0036	CbGpPWpGaD
Vandetanib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00146	0.00356	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—ABCB4—sclerosing cholangitis	0.00144	0.00353	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00141	0.00346	CbGpPWpGaD
Vandetanib—SRC—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.0014	0.00342	CbGpPWpGaD
Vandetanib—SRC—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00138	0.00338	CbGpPWpGaD
Vandetanib—ABCG2—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.00137	0.00336	CbGpPWpGaD
Vandetanib—FYN—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00136	0.00334	CbGpPWpGaD
Vandetanib—VEGFA—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.00133	0.00325	CbGpPWpGaD
Vandetanib—KDR—Developmental Biology—TCF4—sclerosing cholangitis	0.00133	0.00325	CbGpPWpGaD
Vandetanib—ABCC1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00128	0.00313	CbGpPWpGaD
Vandetanib—SRC—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.00126	0.00307	CbGpPWpGaD
Vandetanib—SRC—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00124	0.00304	CbGpPWpGaD
Vandetanib—VEGFA—Developmental Biology—TCF4—sclerosing cholangitis	0.00119	0.00292	CbGpPWpGaD
Vandetanib—EGFR—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00118	0.00288	CbGpPWpGaD
Vandetanib—YES1—Developmental Biology—TCF4—sclerosing cholangitis	0.00115	0.00282	CbGpPWpGaD
Vandetanib—LCK—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00113	0.00278	CbGpPWpGaD
Vandetanib—ABCG2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00112	0.00275	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00111	0.00271	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00107	0.00263	CbGpPWpGaD
Vandetanib—ALB—Selenium Micronutrient Network—GGT1—sclerosing cholangitis	0.00106	0.00261	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—ABCB4—sclerosing cholangitis	0.00103	0.00252	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00101	0.00248	CbGpPWpGaD
Vandetanib—SRC—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.001	0.00246	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000925	0.00226	CbGpPWpGaD
Vandetanib—EGFR—Spinal Cord Injury—NOS2—sclerosing cholangitis	0.000925	0.00226	CbGpPWpGaD
Vandetanib—TEK—Hemostasis—NOS2—sclerosing cholangitis	0.000875	0.00214	CbGpPWpGaD
Vandetanib—VEGFA—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.000872	0.00213	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—TCF4—sclerosing cholangitis	0.000859	0.0021	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—TCF4—sclerosing cholangitis	0.000855	0.00209	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—TCF4—sclerosing cholangitis	0.000846	0.00207	CbGpPWpGaD
Vandetanib—MKNK1—Disease—GOT2—sclerosing cholangitis	0.000776	0.0019	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000767	0.00188	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—TCF4—sclerosing cholangitis	0.000731	0.00179	CbGpPWpGaD
Vandetanib—ALB—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000694	0.0017	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—GOT2—sclerosing cholangitis	0.000685	0.00168	CbGpPWpGaD
Vandetanib—MKNK1—Disease—GOT1—sclerosing cholangitis	0.00067	0.00164	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—TCF4—sclerosing cholangitis	0.000623	0.00153	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—GOT1—sclerosing cholangitis	0.000591	0.00145	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—GGT1—sclerosing cholangitis	0.000591	0.00145	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000583	0.00143	CbGpPWpGaD
Vandetanib—FGR—Hemostasis—NOS2—sclerosing cholangitis	0.000564	0.00138	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000515	0.00126	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—GOT2—sclerosing cholangitis	0.00049	0.0012	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—ABCB4—sclerosing cholangitis	0.000479	0.00117	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000471	0.00115	CbGpPWpGaD
Vandetanib—VEGFA—Hemostasis—NOS2—sclerosing cholangitis	0.000471	0.00115	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000471	0.00115	CbGpPWpGaD
Vandetanib—MKNK1—Disease—HIF1A—sclerosing cholangitis	0.000466	0.00114	CbGpPWpGaD
Vandetanib—ERBB3—Disease—GOT2—sclerosing cholangitis	0.00046	0.00112	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000459	0.00112	CbGpPWpGaD
Vandetanib—YES1—Hemostasis—NOS2—sclerosing cholangitis	0.000455	0.00111	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000454	0.00111	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000441	0.00108	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—HIF1A—sclerosing cholangitis	0.00043	0.00105	CbGpPWpGaD
Vandetanib—MKNK1—Disease—NOS2—sclerosing cholangitis	0.000424	0.00104	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—GGT1—sclerosing cholangitis	0.000423	0.00103	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—GOT1—sclerosing cholangitis	0.000423	0.00103	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—ABCB4—sclerosing cholangitis	0.000421	0.00103	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000413	0.00101	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000399	0.000976	CbGpPWpGaD
Vandetanib—ERBB3—Disease—GOT1—sclerosing cholangitis	0.000397	0.000971	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000394	0.000963	CbGpPWpGaD
Vandetanib—LYN—Hemostasis—NOS2—sclerosing cholangitis	0.000339	0.000831	CbGpPWpGaD
Vandetanib—ABL1—Hemostasis—NOS2—sclerosing cholangitis	0.000338	0.000827	CbGpPWpGaD
Vandetanib—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	0.000336	0.000823	CbGpPWpGaD
Vandetanib—FYN—Hemostasis—NOS2—sclerosing cholangitis	0.000334	0.000818	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000326	0.000798	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—GOT2—sclerosing cholangitis	0.000307	0.000752	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000304	0.000743	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000297	0.000728	CbGpPWpGaD
Vandetanib—FYN—Disease—GOT2—sclerosing cholangitis	0.000296	0.000725	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000293	0.000716	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—NOS2—sclerosing cholangitis	0.000278	0.000681	CbGpPWpGaD
Vandetanib—ERBB3—Disease—HIF1A—sclerosing cholangitis	0.000276	0.000675	CbGpPWpGaD
Vandetanib—ABCC1—Disease—GOT2—sclerosing cholangitis	0.000271	0.000664	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—GOT1—sclerosing cholangitis	0.000265	0.000649	CbGpPWpGaD
Vandetanib—ALB—Metabolism—ABCB4—sclerosing cholangitis	0.00026	0.000636	CbGpPWpGaD
Vandetanib—EGFR—Disease—GOT2—sclerosing cholangitis	0.000256	0.000626	CbGpPWpGaD
Vandetanib—FYN—Disease—GOT1—sclerosing cholangitis	0.000256	0.000626	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000253	0.000619	CbGpPWpGaD
Vandetanib—ERBB3—Disease—NOS2—sclerosing cholangitis	0.000251	0.000614	CbGpPWpGaD
Vandetanib—LCK—Disease—GOT2—sclerosing cholangitis	0.000247	0.000603	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—NOS2—sclerosing cholangitis	0.000246	0.000603	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000244	0.000597	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000239	0.000585	CbGpPWpGaD
Vandetanib—ABCC1—Disease—GOT1—sclerosing cholangitis	0.000234	0.000573	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—GOT2—sclerosing cholangitis	0.000227	0.000556	CbGpPWpGaD
Vandetanib—EGFR—Disease—GOT1—sclerosing cholangitis	0.000221	0.00054	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000219	0.000536	CbGpPWpGaD
Vandetanib—SRC—Disease—GOT2—sclerosing cholangitis	0.000218	0.000534	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000216	0.000528	CbGpPWpGaD
Vandetanib—LCK—Disease—GOT1—sclerosing cholangitis	0.000213	0.000521	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000201	0.000491	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—GOT2—sclerosing cholangitis	0.0002	0.000489	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—GGT1—sclerosing cholangitis	0.000196	0.00048	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—GOT1—sclerosing cholangitis	0.000196	0.00048	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000195	0.000478	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000193	0.000473	CbGpPWpGaD
Vandetanib—SRC—Disease—GOT1—sclerosing cholangitis	0.000188	0.000461	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—HIF1A—sclerosing cholangitis	0.000185	0.000452	CbGpPWpGaD
Vandetanib—FYN—Disease—HIF1A—sclerosing cholangitis	0.000178	0.000435	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000176	0.00043	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—GGT1—sclerosing cholangitis	0.000173	0.000423	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—GOT1—sclerosing cholangitis	0.000173	0.000423	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.00017	0.000415	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—NOS2—sclerosing cholangitis	0.000168	0.000411	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—NOS2—sclerosing cholangitis	0.000166	0.000407	CbGpPWpGaD
Vandetanib—ABCC1—Disease—HIF1A—sclerosing cholangitis	0.000163	0.000399	CbGpPWpGaD
Vandetanib—FYN—Disease—NOS2—sclerosing cholangitis	0.000162	0.000396	CbGpPWpGaD
Vandetanib—EGFR—Disease—HIF1A—sclerosing cholangitis	0.000154	0.000376	CbGpPWpGaD
Vandetanib—ABCC1—Disease—NOS2—sclerosing cholangitis	0.000148	0.000363	CbGpPWpGaD
Vandetanib—LCK—Disease—HIF1A—sclerosing cholangitis	0.000148	0.000362	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	0.00014	0.000343	CbGpPWpGaD
Vandetanib—EGFR—Disease—NOS2—sclerosing cholangitis	0.00014	0.000342	CbGpPWpGaD
Vandetanib—LCK—Disease—NOS2—sclerosing cholangitis	0.000135	0.00033	CbGpPWpGaD
Vandetanib—SRC—Disease—HIF1A—sclerosing cholangitis	0.000131	0.000321	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000129	0.000316	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000127	0.00031	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000125	0.000305	CbGpPWpGaD
Vandetanib—ALB—Metabolism—GOT2—sclerosing cholangitis	0.000123	0.000302	CbGpPWpGaD
Vandetanib—SRC—Disease—NOS2—sclerosing cholangitis	0.000119	0.000292	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000108	0.000263	CbGpPWpGaD
Vandetanib—ALB—Metabolism—GGT1—sclerosing cholangitis	0.000107	0.000261	CbGpPWpGaD
Vandetanib—ALB—Metabolism—GOT1—sclerosing cholangitis	0.000107	0.000261	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000104	0.000254	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—HIF1A—sclerosing cholangitis	9.18e-05	0.000225	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	6.66e-05	0.000163	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	5.75e-05	0.000141	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	5.75e-05	0.000141	CbGpPWpGaD
